Ilyang Pharmaceutical Co.,Ltd (007575.KS) KSC
7,800.00
-180(-2.26%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 254.88B |
| Enterprise Value | 358.02B |
| P/E Ratio | 6.95 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 0.54 |
| Price/Book Ratio | 0.55 |
| Enterprise/Revenue | 0.82 |
| Enterprise/EBITDA | 89.59 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | -0.02 |
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 272.24B |
| Revenue/Share | 16,337.39 |
| Gross Profit | 116.35B |
| EBITDA | 13.31B |
| Net Income | 6.9B |
| Diluted EPS | 375.42 |
Balance Sheet
| Total Cash | 38.79B |
| Total Cash/Share | 2,301.43 |
| Total Debt | 112.65B |
| Total Debt/Equity | 0.44 |
| Current Ratio | 0.96 |
| Book Value Per Share | 15,281.21 |
Price History
| 52-Week Change | -40.37 |
| 52-Week High | 16,500 |
| 52-Week Low | 7,770 |
| Moving Average 50 Days | 10,688.2 |
| Moving Average 200 Days | 12,399.9 |
Statistics
| Average Volume | 1,391 |
| Shares Outstanding | 18.17M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 155 |
| Trailing Annual Dividend Yield | 1.86 |
| Payout Ratio | 0.14 |
| Last Split Factor | 2:1 |
| Last Split Date | June 28, 2006 |
